Apoptosis and oxidative status in peripheral blood mononuclear cells of diabetic patients

Apoptosis

Volumn 4, Issue 4, 1999, Pages 263-270

  Graber, R ^a   Farine, J C ^b   Fumagalli, I ^c   Tatti, V ^d   Losa, G A ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

^b OM PHARMA   (Switzerland)

^c Medical Practice   (Switzerland)

^d Medical Practice   (Switzerland)

Author keywords

Apoptosis; B T blood lymphocytes; Glutathione; Glutathione S transferase; Membrane permeability; Type I (IDDM); Type II (NIDDM) diabetes; glutamyltransferase

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN A1C; PROPIDIUM IODIDE;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 0032884138     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1026408409916     Document Type: Article

References (50)

1. Itoh M. Immunological aspects of diabetes mellituts: prospects for pharmacological modification. Pharmacol Ther 1989; 44: 351-406.
2. Faustman D, Eisenbarth G, Daley J, Breitmeyer J. Abnormal T-lymphocyte subsets in type I diabetes. Diabetes 1989; 38: 1462-1468.
3. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell 1997; 89: 1-3.
4. Reeves WG, Wilson RM. Infection, immunity and diabetes. Alberti KG, DeFronzo RA, Keen H and Zimmet P, eds. International Textbook of Diabetes Mellitus. John Wiley & Sons, 1992: 1165-1171.
5. Faustman D, Eisenbarth G, Breitmeyer J. Analysis of T lymphocyte subsets in all stages of diabetes. J Autoimmun Suppl 1990; 1: 111-116.
6. Al-Kassab AS, Raziuddin S. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus. Clin Exp Immunol 1990; 81: 267-271.
7. Pontesilli O, Chase HP, Carotenuto P, Herberger MJ, Hayward AR. T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus. Clin Exp Immunol 1986; 63: 68-72.
8. Roep BO, De Vries RR. T-lymphocytes and the pathogenesis of type 1 (insulin-dependent diabetes mellitus. Eur J Clin Invest 1992; 22: 697-711.
9. Munoz A, Gallart T, Usac EF, Fernandez-Alvarez J, Vinas O, Somoza N, Barcelo J, Gomis R. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5-B lymphocytes in IDDM. Diabetologia 1995; 38: 62-72.
10. Al-Sakkaf L, Pozzilli P, Tarn AC, Schwarz G, Gale EA, Bottazzo GF. Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes. Diabetologia 1989; 32: 322-325.
11. Lorenzi M, Montisano DF, Toledo S, Wong HC. Increased single strand breaks in DNA of lymphocytes from diabetic subjects. J Clin Invest 1987; 79: 656-656.
12. Barbieri D, Grassilli E, Monti D, Salvioli S, Franceschini MG, Franchini A, Bellesia E, Salomoni P, Negro P, Capri M, Troiano L, Cossarizza A, Franceschi C. D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Bioch Biophys Res Commun 1994; 201: 1109-1116.
13. Lorenzi M, Montisano DF, Toledo S, Barrieux A. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 1986; 77: 322-325.
14. Ceriello A, dello Russo P, Amstadt P, Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes 1996; 45: 471-477.
15. Kletsas D, Barbieri D, Stathakos D, Botti B, Bergamini S, Tomasi A, Monti D, Malorni W, Franceschi C. The highly reducing sugar 2-deoxy D ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption. Biochem Biophys Res Commun 1998; 243: 456-425.
16. Ahmed S, Clark A, Matthews DR. Progressive decline of β-cell function in non-insulin-dependent diabetes. Current Opinion in Endocrinology & Diabetes 1998; 4: 300-307.
17. Avruch J. A signal for β-cell failure. Nature 1998; 391: 846-847.
18. Mauricio D, Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 1998; 47: 1537-1543.
19. Giordano C, De Maria R, Stassi G, Todaro M, Richiusa P, Giordano M, Testi R, Galluzzo A. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM. Diabetologia 1995; 38: 1449-1454.
20. Giordano C, Stassi G, Todaro M, De Maria R, Richiusa P, Scorsone A, Giordano M, Galluzzo A. Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-dignosed IDDM patients. Diabetologia 1995b; 38: 953-958.
21. Gougeon ML, Lecoeur H, Duliost A, et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1996; 91: 9431-9435.
22. McKenna SL, Cotter TG. Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv Cancer Res 1997; 71: 121-164.
23. Dianzani U, Bragardo M, DiFranco D, Alliaudi C, Scagni P, Buonfiglio D, Redoglia V, Bonissoni S, Correra A, Dianzani I, Ramenghi U. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pedriatic patients with autoimmunity/lymphoproliferation. Blood 1997; 89: 2871-2879.
24. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-445.
25. Anderson D, Yu TW, Phillips BJ, Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat Res 1994; 307: 261-271.
26. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52: 659-666.
27. Droge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, Roth S, Gmünder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 1994; 8: 1131-1138.
28. Morrow CS, Cowan KH. Glutathione-S-transferase and drug resistance. Cancer cells 1990; 2: 15-22.
29. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313-4320.
30. Harris ED. Regulation of antioxidant enzymes. FASEB J 1992; 6: 2675-2683.
31. McCaughan FM, Brown AL, Harrison DJ. The effect of glutathione-S-transferase P on the growth of the Jurkat human T cell line. J Pathol 1994; 172: 357-362.
32. Graber R, Losa GA. Subcellular localization and kinetic properties of phosphatidyl-inositol 4,5 bisphosphate phospholipase C and inositol phosphates enzymes from human peripheral blood mononuclear cells. Enzyme 1989; 14: 17-26.
33. Graber R, Losa GA. Subcellular localization of inositide enzymes in established T cell lines and activated lymphocytes. Anal Cell Pathol 1993; 5: 1-16.
34. Morgenstern R, Meijer J, DePierre JW, Ernster J. Characterization of rat-liver microsomal glutathione-S-transferase activity. Eur J Biochem 1980; 104: 167-174.
35. Losa GA, Graber R. Modulation of plasma membrane enzymes during apoptosis of human leukemic T-cells induced by glucocorticoids. Fund Clin Immunol 1995; 3: 71-73.
36. Graber R, Losa GA. Changes in the activities of signal transduction and transport membrane enzymesin CEM lymphoblastoid cells by glucocorticoid-induced apoptosis. Anal cell Pathol 1995; 8: 159-176.
37. Afanasyev VN, Korol BA, Matylevich NP, Pechatnikov VA, Umansky SR. The use of flow cytometry for the investigation of cell death. Cytometry 1993; 14: 603-609.
38. Graber R, Farine JC, Losa GA. Calcium dobesilate protects human peripheral blood mononuclear cells from oxidation and apoptosis. Apoptosis 1998; 3: 41-49.
39. Graber R, Losa GA. Apoptosis in human lymphoblastoid cells induced by acivicin, a specific γ-glutamyltransferase inhibitor. Int J Cancer 1995; 62: 443-448.
40. Petersen LD, Duinkerken G, Bruining GJ, vanLier RAW, de Vries RRP, Roep BO. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J of Autoimmunity 1996; 9: 731-737.
41. Fuss IJ, Strober W, Dale JK, Fritz S, Pearlstein GR, Puck JM, Lenardo MJ, Straus SE. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol 1997; 157: 1912-1918.
42. Lamhamedi-Cherradi SE, Luan JJ, Eloy L, Fluteau G, Bach JF, Garchon H. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 1998; 41: 178-184.
43. Perego P, Paolicchi A, Tongiani R, Pompella A, Tonarelli P, Carenini N, Romanelli S, Zunino F. The cell-specific antiproliferative effect of reduced glutathione is mediated by γ-glutamyltranspeptidase-dependent extracellular pro-oxidant resctions. Int J Cancer 1997; 71: 246-250.
44. McMillan DE, Utterback NG, Lapuma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978; 27: 895-900.
45. Miller JA, Gruallese E, Bunn HF. Non-enzymaticglycosilation of erythrocytic membrane proteins. Relevance to diabetes. J Clin Invest 1980; 65: 896-902.
46. Yue DK, McLennan SV, Turtle JR. Pathogenesis of diabetic microangiopathy: the roles of endothelial cells and basement membrane abnormalities. Diabetic Medicine 1992; 9: 218-223.
47. Brownlee M. Glycation and diabetic complications. Diabetes 1994; 43: 836-841.
48. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, Halle H. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 1997; 81: 363-371.
49. Watala C. Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patients. Int J Biochem 1992; 24: 1755-1761.
50. Watala C, Gwozdzinski K, Pluskota E, Walkowiak B, Trojanowski Z, Cierniewski CS. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Thromb Haemostat 1996; 75: 147-153.